Beyond fatigue: Assessing variables associated with sleep problems and use of sleep medications in multiple sclerosis

Clinical Epidemiology

Volumn 2, Issue 1, 2010, Pages 99-106

  Bamer, Alyssa M ^a   Johnson, Kurt L ^a   Amtmann, Dagmar A ^a   Kraft, George H ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Fatigue; Multiple sclerosis; Nonpharmaceutical treatments; Selfmedication; Sleep

Indexed keywords

NON PRESCRIPTION DRUG; PRESCRIPTION DRUG;

ADULT; AGE; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG INTERMITTENT THERAPY; DRUG USE; FATIGUE; FEMALE; HEALTH SURVEY; HUMAN; LEG CRAMP; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NOCTURIA; PAIN; PRESCRIPTION; SCORING SYSTEM; SELF MEDICATION; SELF REPORT; SEX DIFFERENCE; SLEEP DISORDER; VARIANCE;

EID: 77955345885     PISSN: None     EISSN: 11791349     Source Type: Book Series    
DOI: 10.2147/clep.s10425     Document Type: Article

References (43)

1. National Multiple Sclerosis Society. Who gets MS? 2010. Available from: http://www.nationalmssociety.org/about-multiple-sclerosis/whatwe-know-about-ms/who-gets-ms/index.aspx.Accessed March 9, 2010.
2. Crayton HJ, Rossman HS. Managing the symptoms of multiple sclerosis: a multimodal approach. Clin Ther. 2006;28(4):445-460.
3. Bamer AM, Johnson KL, Amtmann D, Kraft GH. Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler. 2008;14(8): 1127-1130.
4. Tachibana N, Howard RS, Hirsch NP, Miller DH, Moseley IF, Fish D. Sleep problems in multiple sclerosis. Eur Neurol. 1994;34(6):320-323.
5. Manocchia M, Keller S, Ware JE. Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill. Qual Life Res. 2001;10(4):331-345.
6. Merlino G, Fratticci L, Lenchig C, et al. Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med. 2009;10(1):26-34.
7. Attarian HP, Brown KM, Duntley SP, Carter JD, Cross AH. The relationship of sleep disturbances and fatigue in multiple sclerosis. Arch Neurol. 2004;61(4):525-528.
8. Hossain JL, Ahmad P, Reinish LW, Kayumov L, Hossain NK, Shapiro CM. Subjective fatigue and subjective sleepiness: two independent consequences of sleep disorders? J Sleep Res. 2005;14(3):245-253.
9. Kaynak H, Altintas A, Kaynak D, et al. Fatigue and sleep disturbance in multiple sclerosis. Eur J Neurol. 2006;13(12):1333-1339.
10. Merkelbach S, Schulz H. What have fatigue and sleepiness in common? J Sleep Res. 2006;15(1):105-106.
11. Stanton BR, Barnes F, Silber E. Sleep and fatigue in multiple sclerosis. Mult Scler. 2006;12(4):481-486.
12. Strober LB, Arnett PA. An examination of four models predicting fatigue in multiple sclerosis. Arch Clin Neuropsychol. 2005;20(5):631-646.
13. Benca RM, Peterson MJ. Insomnia and depression. Sleep Med. 2008; 9 Suppl 1:S3-S9.
14. Pallesen S, Nordhus IH, Omvik S, Sivertsen B, Tell GS, Bjorvatn B. Prevalence and risk factors of subjective sleepiness in the general adult population. Sleep. 2007;30(5):619-624.
15. Fleming WE, Pollak CP. Sleep disorders in multiple sclerosis. Semin Neurol. 2005;25(1):64-68.
16. Johnson KL, Bamer AM, Fraser RF. Disease and demographic characteristics associated with unemployment among working age adults with multiple sclerosis. International Journal of MS Care. 2009;11(3):137-143.
17. Johnson KL, Bamer AM, Yorkston KM, Amtmann D. Use of cognitive aids and other assistive technology by individuals with multiple sclerosis. Disabil Rehabil Assist Technol. 2009;4(1):1-8.
18. Hays R, Stewart A. Sleep measures. In: Stewart A, Ware J, editor. Measuring Functioning and Well-being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press; 1992.
19. Spritzer KL, Hays RD. MOS Sleep Scale: A Manual for Use and Scoring, Version 1.0. Los Angeles, CA; RAND; 2003.
20. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a selfreport version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737-1744.
21. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
22. Cannon DS, Tiffany ST, Coon H, Scholand MB, McMahon WM, Leppert MF. The PHQ-9 as a brief assessment of lifetime major depression. Psychol Assess. 2007;19(2):247-251.
23. Lamers F, Jonkers CC, Bosma H, Penninx BW, Knottnerus JA, van Eijk JT. Summed score of the Patient Health Questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. J Clin Epidemiol. 2008;61(7):679-687.
24. Martin A, Rief W, Klaiberg A, Braehler E. Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. Gen Hosp Psychiatry. 2006;28(1):71-77.
25. Fann JR, Bombardier CH, Dikmen S, et al. Validity of the Patient Health Questionnaire-9 in assessing depression following traumatic brain injury. J Head Trauma Rehabil. 2005;20(6):501-511.
26. Lowe B, Spitzer RL, Grafe K, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord. 2004;78(2):131-140.
27. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 1994; 21(1):9-14.
28. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18 Suppl 1:S79-S83.
29. Tellez N, Rio J, Tintore M, Nos C, Galan I, Montalban X. Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? Mult Scler. 2005;11(2):198-202.
30. Bowen J, Gibbons L, Gianas A, Kraft GH. Self-administered expanded disability status Scale with functional system scores correlates well with a physician-administered test. Mult Scler. 2001;7(3):201-206.
31. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50(2):133-149.
32. Jensen M, Karoly P. Self-report scales and procedures for assessing pain in adults. In: Turk DC, Melzack R, editors. Handbook of Pain Assessment (2nd ed). New York, NY: Guilford; 2000:135-151.
33. Ferri R, Lanuzza B, Cosentino FI, et al. A single question for the rapid screening of restless legs syndrome in the neurological clinical practice. Eur J Neurol. 2007;14(9):1016-1021.
34. Johnson EO, Roehrs T, Roth T, Breslau N. Epidemiology of alcohol and medication as aids to sleep in early adulthood. Sleep. 1998;21(2): 178-186.
35. Roehrs T, Hollebeek E, Drake C, Roth T. Substance use for insomnia in metropolitan Detroit. J Psychosom Res. 2002;53(1):571-576.
36. Allen KD, Renner JB, DeVellis B, Helmick CG, Jordan JM. Racial differences in sleep medication use: a cross-sectional study of the Johnston County Osteoarthritis Project. Ann Pharmacother. 2008; 42(9):1239-1246.
37. Tononi G, Cirelli C. Sleep function and synaptic homeostasis. Sleep Med Rev. 2006;10(1):49-62.
38. Burke M, Mahurin R, Bowen JD. Differential brain compensation for cognitive versus motor processes in early relapsing-remitting multiple sclerosis subjects without clinical impairment. Mult Scler. 2006;12: S43-S44.
39. Doerr JP, Hirscher V, Riemann D, Voderholzer U. [Disturbances of slow-wave sleep and psychiatric disorders.]. Nervenarzt. 2010;81(3): 347-354.
40. Stepanski EJ, Wyatt JK. Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev. 2003;7(3):215-225.
41. Dolan DC, Taylor DJ, Bramoweth AD, Rosenthal LD. Cognitivebehavioral therapy of insomnia: A clinical case series study of patients with co-morbid disorders and using hypnotic medications. Behav Res Ther. 2010;48(4):321-327.
42. Becker PM, Sattar M. Treatment of sleep dysfunction and psychiatric disorders. Curr Treat Options Neurol. 2009;11(5):349-357.
43. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 2000;162(2): 225-233.